Clinical trials
Observational Hypertension, Pulmonary trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 7 |
| Unknown status | 4 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Terminated | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 4 |
| Royal United Hospitals Bath NHS Foundation Trust | 4 |
| Bayer | 2 |
| Golden Jubilee National Hospital | 2 |
| Oxford University Hospitals NHS Trust | 2 |
| Papworth Hospital NHS Foundation Trust | 2 |
| Actelion | 1 |
| GlaxoSmithKline | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Medical University of Graz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 29 |
| Pulmonary Arterial Hypertension | 3 |
| Disease | 2 |
| Familial Primary Pulmonary Hypertension | 2 |
| Scleroderma, Systemic | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Cardiovascular Diseases | 1 |
| Congenital Portosystemic Shunt | 1 |
| Esophageal Neoplasms | 1 |
| Gastroesophageal Reflux | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.